OGN vs UNIT · P/E 3.4, rev $6.40B vs P/E 2.7, rev $722.6M
Organon & Co (OGN) versus Uniti Group Inc (UNIT) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Uniti Group Inc (UNIT) is a reit - specialty company listed on NASDAQ.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported UNIT revenue for 2025-09-30 was $722.6M. Net income was $1.61B. Revenue was up 147.3% from 2024-09-30 to 2025-09-30. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
Not investment advice. Open the OGN and UNIT stock pages for the full models.
Not investment advice.